Whales with a great deal of cash to invest have actually taken a significantly bullish position on uniQure
Taking a look at choices history for uniQure (NASDAQ: QURE) we identified 53 trades.
If we think about the specifics of each trade, it is precise to state that 60% of the financiers opened trades with bullish expectations and 35% with bearish.
From the general spotted trades, 16 are puts, for an overall quantity of $1,759,721 and 37, calls, for an overall quantity of $3,331,788.
Projected Cost Targets
Based upon the trading activity, it appears that the substantial financiers are going for a rate area extending from $10.0 to $100.0 for uniQure over the current 3 months.
Volume & & Open Interest Trends
Analyzing the volume and open interest supplies important insights into stock research study. This details is type in evaluating liquidity and interest levels for uniQure’s choices at specific strike costs. Listed below, we provide a picture of the patterns in volume and open interest for calls and puts throughout uniQure’s substantial trades, within a strike cost variety of $10.0 to $100.0, over the previous month.
uniQure Choice Activity Analysis: Last one month
Noteworthy Options Activity:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Cost | Strike Cost | Overall Trade Cost | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QURE | CALL | SWEEP | BULLISH | 04/17/26 | $ 7.7 | $ 6.8 | $ 7.7 | $ 40.00 | $ 764.2 K | 70 | 2.0 K |
| QURE | PUT | TRADE | BULLISH | 01/16/26 | $ 34.7 | $ 32.5 | $ 32.5 | $ 60.00 | $ 650.0 K | 307 | 200 |
| QURE | CALL | SWEEP | BEARISH | 04/17/26 | $ 6.4 | $ 3.8 | $ 5.9 | $ 45.00 | $ 365.8 K | 34 | 945 |
| QURE | PUT | TRADE | BULLISH | 11/21/25 | $ 17.0 | $ 14.0 | $ 15.0 | $ 40.00 | $ 240.0 K | 1.6 K | 6 |
| QURE | CALL | TRADE | BULLISH | 01/16/26 | $ 19.8 | $ 16.8 | $ 19.0 | $ 10.00 | $ 190.0 K | 819 | 216 |
About uniQure
uniQure NV is a gene treatment business. It establishes treatments and platforms for clients experiencing hereditary and other terrible illness. Its services and products are concentrated on hemophilia, Huntington’s illness, and heart diseases. The business is concentrated on the advancement of the pipeline of gene treatments with the cooperation of Bristol Myers Squibb for heart diseases.
After an extensive evaluation of the choices trading surrounding uniQure, we transfer to analyze the business in more information. This consists of an evaluation of its present market status and efficiency.
Existing Position of uniQure
- With a volume of 8,655,320, the cost of QURE is down -58.77% at $27.91.
- RSI signs hint that the underlying stock might be oversold.
- Next incomes are anticipated to be launched in 11 days.
Specialist Viewpoints on uniQure
In the last month, 1 professionals launched scores on this stock with a typical target cost of $110.0.
Turn $1000 into $1270 in simply 20 days?
20-year professional choices trader exposes his one-line chart method that reveals when to purchase and offer. Copy his trades, which have actually had balanced a 27% earnings every 20 days. Click on this link for gain access to
* An expert from HC Wainwright & & Co. continues with their Buy ranking on uniQure, preserving a target cost of $110.
Options trading provides greater dangers and possible benefits. Astute traders handle these dangers by constantly informing themselves, adjusting their techniques, keeping an eye on numerous signs, and keeping a close eye on market motions. Stay notified about the most recent uniQure choices trades with real-time informs from Benzinga Pro.